• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE acquires Ambassador Medical

Article

The buying spree continued for GE Medical Systems with its acquisition in early January of Ambassador Medical, a refurbisher and distributor of used ultrasound equipment. Terms of the deal were not disclosed. Ambassador, which has about 40 employees, was

The buying spree continued for GE Medical Systems with its acquisition in early January of Ambassador Medical, a refurbisher and distributor of used ultrasound equipment. Terms of the deal were not disclosed. Ambassador, which has about 40 employees, was acquired to provide customers with more options for managing their ultrasound equipment, according to GE. Company strategists are planning to establish a Center of Excellence for refurbished ultrasound equipment at the Ambassador Medical facility in Carmel, IN.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
Breast MRI and Ultrasound Findings Linked to Elevated Risk of Axillary Residual Disease After Neoadjuvant Therapy

Breast MRI and Ultrasound Findings Linked to Elevated Risk of Axillary Residual Disease After Neoadjuvant Therapy

Jeff Hall
February 10th 2025
Article

Anterior tumor location was over 14 times more likely to be associated with axillary metastasis after neoadjuvant treatment for breast cancer, according to new breast MRI and ultrasound research.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

Jeff Hall
September 1st 2023
Podcast

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

Ultrasound Molecular Agent Gets FDA Fast Track Designation for Active Bowel Inflammation with Crohn’s Disease

Ultrasound Molecular Agent Gets FDA Fast Track Designation for Active Bowel Inflammation with Crohn’s Disease

Jeff Hall
February 7th 2025
Article

Phase 2 studies of the BR55 ultrasound contrast agent reportedly demonstrated a 95 percent accuracy in showing the expression of vascular endothelial growth factor receptor 2 (VEGFR2) in bowel segments reflecting active inflammation in patients with Crohn’s disease.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2

Jeff Hall
August 23rd 2023
Podcast

In the second episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recent studies published by the Journal of the American Medical Association (JAMA) that suggested moving to more of a risk-adapted model for mammography screening.

What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa

What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa

Jeff Hall
February 6th 2025
Article

The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.

Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection

Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection

Jeff Hall
February 5th 2025
Article

Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.

© 2025 MJH Life Sciences

All rights reserved.